Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

@article{Cosgrove2006FinancialTB,
  title={Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry},
  author={L. Cosgrove and S. Krimsky and Manisha Vijayaraghavan and Lisa Schneider},
  journal={Psychotherapy and Psychosomatics},
  year={2006},
  volume={75},
  pages={154 - 160}
}
Background: Increasing attention has been given to the transparency of potential conflicts of interest in clinical medicine and biomedical sciences, particularly in journal publishing and science advisory panels. The authors examined the degree and type of financial ties to the pharmaceutical industry of panel members responsible for revisions of the Diagnostic and Statistical Manual of Mental Disorders(DSM). Methods: By using multimodal screening techniques the authors investigated the… Expand
Conflicts of Interest and Disclosure in the American Psychiatric Association’s Clinical Practice Guidelines
TLDR
Ninety percent of the authors of 3 major CPG in psychiatry had financial ties to companies that manufacture drugs which were explicitly or implicitly identified in the guidelines as recommended therapies for the respective mental illnesses. Expand
Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5
TLDR
The findings suggest that increased transparency and mandatory disclosure policies alone may not be robust enough strategies to prevent the appearance of bias in both the DSM revision process as well as clinical decisions about appropriate interventions for DSM disorders. Expand
[Financial conflict of interest in clinical psychiatry studies: a review].
TLDR
The aim of this review was to evaluate the effect of conflict of interest on outcomes in clinical psychiatry studies and found biased outcomes were significantly more common in industry-funded studies than in non-industry funded ones. Expand
Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression
TLDR
It may be that both transparency and management of industry associations of guideline development groups (GDGs) have improved and some progress has been made, but organizations that develop guidelines should continue to work toward greater transparency and minimization of financial conflicts of interest. Expand
Toward Credible Conflict of Interest Policies in Clinical Psychiatry
A recent letter to the American Psychiatric Association (APA) from Sen Chuck Grassley about the APA’s financial relationship with pharmaceutical companies raises concerns about undue industryExpand
Industry’s colonization of psychiatry: Ethical and practical implications of financial conflicts of interest in the DSM-5
The revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM), scheduled for publication in May 2013 by the American Psychiatric Association (APA), has created a firestorm ofExpand
Financial conflicts of interest in psychiatry FORUM: FINANCIAL CONFLICTS OF INTEREST IN PSYCHIATRY
The proliferating connections between physicians and the pharmaceutical industry have brought the credibility of clinical medicine to an unprecedented crisis (1). The public seems to be increasinglyExpand
Ethical Problems in the Relationship of P s ychiatry to the Pharmaceutical Industry
TLDR
Two Harvard research psychiatrists, whose work has encouraged the use of antipsychotic medication in children, failed to report to the university most of their consulting income from pharmaceutical companies, skirting a requirement that involvement in human subjects’ research be free of personal industry remuneration. Expand
The influence of corporate and political interests on models of illness in the evolution of the DSM
TLDR
This article will outline the development of a medical model of mental illness, highlighting connections between this model and corporate and political interests, and will show how this model relates to the various revisions of, and developments within, the DSM. Expand
Expanding the Market
Once pharmaceutical companies obtained FDA approval for their new psychiatric medications, they naturally wanted to maximize the sale of their products. This meant expanding the pool of potentialExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
TLDR
Original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research are reviewed to show a statistically significant association between industry sponsorship and pro-industry conclusions. Expand
Policies on faculty conflicts of interest at US universities.
TLDR
Most policies on conflict of interest in a sample of major research institutions in the United States lack specificity about the kinds of relationships with industry that are permitted or prohibited, and wide variation in management of conflicts of interest among institutions may cause unnecessary confusion. Expand
Assessing faculty financial relationships with industry: A case study.
TLDR
The extent to which faculty researchers have personal financial relationships with the sponsors of their research, the nature of those financial relationships, and efforts made at the institutional level to address disclosed financial relationships and perceived conflicts of interest are assessed. Expand
Conflicts of interest in biomedical research.
TLDR
This Commentary addresses financial conflicts of interest in academic biomedical research and the nation’s medical schools and teaching hospitals, which remain the fount of new medical knowledge from which most novel diagnostic methods and treatments derive, may have been insufficiently responsive to the profound changes that have transformed the culture of academic medicine. Expand
Financial interests of authors in scientific journals: A pilot study of 14 publications
TLDR
The frequency of selected financial interests held among authors of certain types of scientific publications and assesses disclosure practices of authors is measured and implications for the new conflict of interest guidelines and disclosure policies are discussed. Expand
Conflict of interest policies in science and medical journals: Editorial practices and author disclosures
This study examines the extent to which scientific and biomedical journals have adopted conflict of interest (COI) policies for authors, and whether the adoption and content of such policies leads toExpand
What do we really know about conflicts of interest in biomedical research?
TLDR
Some evidence exists to indicate that researchers with conflicting interests may indeed offer different professional opinions and judgments than those for whom such conflicts do not exist, and the effectiveness of various disclosure and management methods for conflicts of interest is unknown. Expand
Raising Questions about Antidepressants
TLDR
The evidence suggests that psychological interventions are at least as effective as pharmacotherapy in treating depression, even if severe, especially when patient-rated measures are used and long-term follow-up is considered. Expand
Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial
TLDR
The effects on reader perceptions of different statements of competing interests for two manuscripts are reported and the authors' conclusions and readers' perceptions of published studies are reported. Expand
Conflict of Interest and Special Interest Groups
  • G. Fava
  • Psychology
  • Psychotherapy and Psychosomatics
  • 2001
Accessible online at: www.karger.com/journals/pps The issue of conflict of interest is attracting increasing attention in medical journals. The notion of conflict of interest is widely used but mayExpand
...
1
2
3
4
5
...